Related Experiment Video
Updated: Jun 2, 2026

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Prostate cancer 2010. Therapeutic innovations]
1Département de Radiothérapie Oncologique, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France.
Summary
Exploring prostate cancer treatment innovations, this review discusses radiation dose escalation techniques like brachytherapy and intensity-modulated radiotherapy, and the role of hormonal therapies before and after treatment for relapse.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Context:
- Annual congress of the SFRO (Société Française de Radiothérapie Oncologique)
- Symposium on 'Therapeutic Innovations' in prostate cancer treatment
Purpose:
- To summarize current debates and burning questions in prostate cancer therapy.
- To highlight key areas of ongoing research and clinical discussion.
Summary:
- Discussion on optimal radiation dose escalation techniques: brachytherapy versus Intensity-Modulated Radiotherapy (IMRT), with acknowledged rationales but lacking comparative trial data.
- Exploration of neoadjuvant hormonal treatment, particularly Luteinizing Hormone-Releasing Hormone (LH-RH) antagonists, for their rapid anti-hormonal effects prior to surgery or radiotherapy.
- Review of salvage treatment options for biochemical relapse post-external beam irradiation, including surgery, cryotherapy, High-Intensity Focused Ultrasound (HIFU), and the timing of hormonal interventions.
Impact:
- Identifies critical areas requiring further research, such as prospective comparative trials for radiation techniques.
- Underscores the evolving role and optimal application of hormonal therapies in prostate cancer management.
- Provides insights into the multidisciplinary approach for managing recurrent prostate cancer after primary radiation therapy.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

